Published ahead of print on January 15, 2004, doi:10.1164/rccm.200208-960OC
Am. J. Respir. Crit. Care Med., Volume 169, Number 7, April 2004, 842-849
A more recent version of this article appeared on April 1, 2004
Submitted on September 9, 2002
Accepted on January 13, 2004
Asthma Exacerbations After Glucocorticoid Withdrawal Reflects T Cell Recruitment to the Airway
Mario Castro1*, Sharon R Bloch1, Michelle V Jenkerson1, Steve DeMartino1, Daniel L Hamilos2, Rebecca B Cochran1, E Xueping1, Liang Zhang1, Haochuan Wang1, Joseph P Bradley1, Kenneth B Schechtman3, and Michael J Holtzman1
1 Division of Pulmonary and Critical Care Medicine and Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA,
2 Washington University School of Medicine, St. Louis, MO, USA,
3 Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA
* To whom correspondence should be addressed. E-mail: castrom{at}wustl.edu.
We reasoned that a prospective assessment of glucocorticoid withdrawal in subjects with asthma would provide insight into the basis for flares of the disease. We therefore enrolled 25 subjects with moderate persistent asthma and treated them for 30 d with inhaled fluticasone proprionate (1760 µg/d) followed by a withdrawal period that lasted until peak expiratory airflow decreased by 25% and forced expiratory volume in 1 sec by 15% or 6 wk elapsed. After glucocorticoid withdrawal, 13 of 25 subjects reached the target while 12 subjects did not. The number of eosinophils in bronchial biopsies was increased by glucocorticoid withdrawal in both groups, but increases in airway T cells were found only in those with exacerbation. T cell accumulation was a reflection of similar increases in both CD4+ and CD8+ T cells and was accompanied by increased expression of chemokine CCL5 (RANTES) in the airway epithelium without activation of the transcription factor NF- B. The pattern of glucocorticoid-sensitive inflammation during an asthma exacerbation is more reminiscent of an anti-viral response than an eosinophil-predominant response to allergen and implies an independent role for airway T cells in mediating asthma flares and in determining glucocorticoid efficacy in the treatment of this disease.
Key words: airway inflammation, airway hyperreactivity, airway epithelium
This article has been cited by other articles:

|
 |

|
 |
 
K. D. Nguyen, A. Fohner, J. D. Booker, C. Dong, A. M. Krensky, and K. C. Nadeau
XCL1 Enhances Regulatory Activities of CD4+CD25highCD127low/- T Cells in Human Allergic Asthma
J. Immunol.,
October 15, 2008;
181(8):
5386 - 5395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cohen, X. E, J. Tarsi, T. Ramkumar, T. K. Horiuchi, R. Cochran, S. DeMartino, K. B. Schechtman, I. Hussain, M. J. Holtzman, et al.
Epithelial Cell Proliferation Contributes to Airway Remodeling in Severe Asthma
Am. J. Respir. Crit. Care Med.,
July 15, 2007;
176(2):
138 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Qiu, J. Zhu, V. Bandi, K. K Guntupalli, and P. K Jeffery
Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma
Thorax,
June 1, 2007;
62(6):
475 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Siegle, N. Hansbro, C. Herbert, M. Yang, P. S. Foster, and R. K. Kumar
Airway Hyperreactivity in Exacerbation of Chronic Asthma Is Independent of Eosinophilic Inflammation
Am. J. Respir. Cell Mol. Biol.,
November 1, 2006;
35(5):
565 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Culley, A. M. J. Pennycook, J. S. Tregoning, J. S. Dodd, G. Walzl, T. N. Wells, T. Hussell, and P. J. M. Openshaw
Role of CCL5 (RANTES) in Viral Lung Disease.
J. Virol.,
August 1, 2006;
80(16):
8151 - 8157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Grayson and M. J. Holtzman
Chemokine Complexity: The Case for CCL5.
Am. J. Respir. Cell Mol. Biol.,
August 1, 2006;
35(2):
143 - 146.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Georas, J. Guo, U. De Fanis, and V. Casolaro
T-helper cell type-2 regulation in allergic disease
Eur. Respir. J.,
December 1, 2005;
26(6):
1119 - 1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Holtzman, J. W. Tyner, E. Y. Kim, M. S. Lo, A. C. Patel, L. P. Shornick, E. Agapov, and Y. Zhang
Acute and Chronic Airway Responses to Viral Infection: Implications for Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
August 1, 2005;
2(2):
132 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Walter and M. J. Holtzman
A Centennial History of Research on Asthma Pathogenesis
Am. J. Respir. Cell Mol. Biol.,
June 1, 2005;
32(6):
483 - 489.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Busse, S. Banks-Schlegel, P. Noel, H. Ortega, V. Taggart, and J. Elias
Future Research Directions in Asthma: An NHLBI Working Group Report
Am. J. Respir. Crit. Care Med.,
September 15, 2004;
170(6):
683 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|